An anonymous director reports

CANNVAS MEDTECH ANNOUNCES OPTION GRANTS

Cannvas Medtech Inc. has granted incentive stock options to purchase a total of 630,000 common shares at an exercise price of 37 cents per share for a period of five years to a director and certain consultants in accordance with the provisions of its stock option plan.

About Cannvas Medtech Inc.

Cannvas Medtech is a leading business technology company in the cannabis space. It designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry and key business drivers.

We seek Safe Harbor.